Global Cardiovascular Drug-Eluting Stents(DES) Market Growth 2023-2029

Global Cardiovascular Drug-Eluting Stents(DES) Market Growth 2023-2029

The global Cardiovascular Drug-Eluting Stents(DES) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cardiovascular Drug-Eluting Stents(DES) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cardiovascular Drug-Eluting Stents(DES) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cardiovascular Drug-Eluting Stents(DES) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cardiovascular Drug-Eluting Stents(DES) players cover MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin and Terumo Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects

LPI (LP Information)' newest research report, the “Cardiovascular Drug-Eluting Stents(DES) Industry Forecast” looks at past sales and reviews total world Cardiovascular Drug-Eluting Stents(DES) sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Drug-Eluting Stents(DES) sales for 2023 through 2029. With Cardiovascular Drug-Eluting Stents(DES) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Drug-Eluting Stents(DES) industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Drug-Eluting Stents(DES) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Drug-Eluting Stents(DES) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Drug-Eluting Stents(DES) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Drug-Eluting Stents(DES) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Drug-Eluting Stents(DES).

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Drug-Eluting Stents(DES) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Passive Coating
Active Coating

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Boston Scientific
MicroPort Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Drug-Eluting Stents(DES) market?

What factors are driving Cardiovascular Drug-Eluting Stents(DES) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Drug-Eluting Stents(DES) market opportunities vary by end market size?

How does Cardiovascular Drug-Eluting Stents(DES) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.